Condition: Sudden Cardiac Arrest · Sudden Cardiac Death · Sudden Cardiac Death Due to Cardiac Arrhythmia · Sponsor: Tampere Heart Hospital
The goal of this observational study is to recognize clinical and genetic risk factors for sudden cardiac arrest (SCA) and death (SCD) in patients with coronary artery disease (CAD). The main questions it aims to answer are: Are we able to recognize clinical or treatment-related risk factors for SCA or SCD? Can we identify new genetic risk factors for SCA or SCD in patients under 75 years? Participants diagnosed with CAD answer a short survey about their medical history and socioeconomic status. A standard ECG addition to a five (5) minute ECG recording is taken from all the study subjects. In addition to a few short physiological tests (e.g. blood pressure, height, weight, grip strength), a blood sample is withdrawn from a selected group of study subjects. Medical healthcare records are used to follow all study subjects, and no follow-up visits are required.
This description comes directly from the study's public registry record.
Jussi Hernesniemi, Professor · jussi.hernesniemi@tuni.fi
Juho Tynkkynen, Medical Doctor, Phd · +358 3 311 611 · juho.tynkkynen@pirha.fi
Always discuss trial participation with your own doctor first.
| Tampere University Hospital Tampere Heart Centre | Tampere, Pirkanmaa, Finland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06804499